TY - JOUR
T1 - Magnetite nanoparticles functionalized with rnases against intracellular infection of pseudomonas aeruginosa
AU - Rangel-Muñoz, Nathaly
AU - Suarez-Arnedo, Alejandra
AU - Anguita, Raúl
AU - Prats-Ejarque, Guillem
AU - Osma, Johann F.
AU - Muñoz-Camargo, Carolina
AU - Boix, Ester
AU - Cruz, Juan C.
AU - Salazar, Vivian A.
N1 - Funding Information:
Funding: This research was funded by Colciencias Grant Contract #689-2018, Colciencias Grant contract #811-2019, which provided the funds for the postdoctoral stay of Vivian Angelica Salazar Montoya at Universidad de los Andes. We would also like to thank the Department of Electrical and Electronic Engineering and the Department of Biomedical Engineering as well as the funding provided by the Fondo de Apoyo a Profesores Asistentes grant to Carolina Muñoz-Camargo at the Universidad de los Andes. Experimental work was also supported by the Fundació La Marató de TV3 (ref. 20180310) Grant to Ester Boix.
Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2020/7
Y1 - 2020/7
N2 - Current treatments against bacterial infections have severe limitations, mainly due to the emergence of resistance to conventional antibiotics. In the specific case of Pseudomonas aeruginosa strains, they have shown a number of resistance mechanisms to counter most antibiotics. Human secretory RNases from the RNase A superfamily are proteins involved in a wide variety of biological functions, including antimicrobial activity. The objective of this work was to explore the intracellular antimicrobial action of an RNase 3/1 hybrid protein that combines RNase 1 high catalytic and RNase 3 bactericidal activities. To achieve this, we immobilized the RNase 3/1 hybrid on Polyetheramine (PEA)-modified magnetite nanoparticles (MNPs). The obtained nanobioconjugates were tested in macrophage-derived THP-1 cells infected with Pseudomonas aeruginosa PAO1. The obtained results show high antimicrobial activity of the functionalized hybrid protein (MNP-RNase 3/1) against the intracellular growth of P. aeruginosa of the functionalized hybrid protein. Moreover, the immobilization of RNase 3/1 enhances its antimicrobial and cell-penetrating activities without generating any significant cell damage. Considering the observed antibacterial activity, the immobilization of the RNase A superfamily and derived proteins represents an innovative approach for the development of new strategies using nanoparticles to deliver antimicrobials that counteract P. aeruginosa intracellular infection.
AB - Current treatments against bacterial infections have severe limitations, mainly due to the emergence of resistance to conventional antibiotics. In the specific case of Pseudomonas aeruginosa strains, they have shown a number of resistance mechanisms to counter most antibiotics. Human secretory RNases from the RNase A superfamily are proteins involved in a wide variety of biological functions, including antimicrobial activity. The objective of this work was to explore the intracellular antimicrobial action of an RNase 3/1 hybrid protein that combines RNase 1 high catalytic and RNase 3 bactericidal activities. To achieve this, we immobilized the RNase 3/1 hybrid on Polyetheramine (PEA)-modified magnetite nanoparticles (MNPs). The obtained nanobioconjugates were tested in macrophage-derived THP-1 cells infected with Pseudomonas aeruginosa PAO1. The obtained results show high antimicrobial activity of the functionalized hybrid protein (MNP-RNase 3/1) against the intracellular growth of P. aeruginosa of the functionalized hybrid protein. Moreover, the immobilization of RNase 3/1 enhances its antimicrobial and cell-penetrating activities without generating any significant cell damage. Considering the observed antibacterial activity, the immobilization of the RNase A superfamily and derived proteins represents an innovative approach for the development of new strategies using nanoparticles to deliver antimicrobials that counteract P. aeruginosa intracellular infection.
KW - Antimicrobials
KW - Magnetite nanoparticles
KW - Pseudomonas aeruginosa
KW - Ribonucleases
UR - http://www.scopus.com/inward/record.url?scp=85088778426&partnerID=8YFLogxK
U2 - 10.3390/pharmaceutics12070631
DO - 10.3390/pharmaceutics12070631
M3 - Article
AN - SCOPUS:85088778426
VL - 12
SP - 1
EP - 25
JO - Pharmaceutics
JF - Pharmaceutics
SN - 1999-4923
IS - 7
M1 - 631
ER -